High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$25.3M
$25,292,800
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| GENB |
Generate Biomedicines, Inc.
|
CEO
Discretionary Buy
|
2026-03-04 | $240,000 | P | Form 4 |
|
GENB
P
Generate Biomedicines, Inc.
AFEYAN NOUBAR
• Director
Discretionary BuyΔOwn +11.4%
2026-03-02
$25,000,000MEGA
|
||||||
| GENB |
Generate Biomedicines, Inc.
|
Director
Discretionary BuyΔOwn +11.4%
|
2026-03-02 | $25,000,000MEGA | P | Form 4 |
| GENB |
Generate Biomedicines, Inc.
|
Director
Discretionary Buy
|
2026-03-02 | $24,000 | P | Form 4 |
| GENB |
Generate Biomedicines, Inc.
|
CFO
Discretionary Buy
|
2026-03-02 | $8,000 | P | Form 4 |
| GENB |
Generate Biomedicines, Inc.
|
CFO
Discretionary Buy
|
2026-03-02 | $16,000 | P | Form 4 |
|
GENB
P
Generate Biomedicines, Inc.
Grous Beth
• Officer • Chief People Officer
Discretionary Buy
2026-03-02
$4,800
|
||||||
| GENB |
Generate Biomedicines, Inc.
|
Officer • Chief People Officer
Discretionary Buy
|
2026-03-02 | $4,800 | P | Form 4 |